Summer Sale
50% off Premium Yearly
NYSE:WAT
Waters Corp (WAT)
Financials 
Technical Analysis 
Jun 19, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
Waters Corp. (WAT-N) has experienced notable fluctuations in its stock performance this year, particularly following the strategic acquisition of Becton Dickinson's biosciences and diagnostic solutions business last July. Despite an initial drop in shares, which seemed unwarranted to some, the stock has rebounded impressively, gaining 45%. In the latest quarter, the company reported an 8% increase in revenue alongside improved earnings, while also boosting its full-year forecast, indicating optimism about ongoing growth. However, the acquisition of part of BDX for $17.5 billion initially triggered a significant 13.81% decline in WAT's shares, reflecting a negative market reaction to the deal. Nonetheless, analysts suggest that this adjustment may be excessive given the strategic benefits of the acquisition for both companies.
Life sciences suffered post-Covid after rallying during Covid. WAT is a major player. Last Wednesday they reperted a clean top/bottom line beat, but issued a cautious earnings forecast, so the market gave a muted reaction. Likes them, because they have few competitors at at time when the economy is slowing down.
WAT vs. TMO vs. DHR Not performing as well as Thermo Fisher or Danaher. Cash from operations has been flat in the last 4 years, whereas the other two have doubled, which is reflected in the stock price. Market share, operating margins, and pricing power impact the business model. Compare these when assessing competitors in an industry.
- «
- ‹
- 1
- ›
- »
Waters Corp (WAT) Frequently Asked Questions
What is Waters Corp stock symbol?
Waters Corp is a American stock, trading under the symbol WAT (previously WAT-N on Stockchase) on the New York Stock Exchange (WAT). It is usually referred to as NYSE:WAT or WAT
Is Waters Corp a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on WAT (previously WAT-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Waters Corp.
Is Waters Corp a good investment or a top pick?
Waters Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Waters Corp.
Why is Waters Corp stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Waters Corp.
Is Waters Corp worth watching?
Waters Corp is followed by 6 investors on Stockchase and is a trending stock that is worth watching.
What is Waters Corp stock price?
On 2026-06-18, Waters Corp (WAT) stock closed at a price of $355.45.
The stock was doing well into early this year when they combined Becton Dickinson's biosciences & diagnostic solutions business last July. Shares plunged, which he didn't understand, but have since turned around, up 45%. They reported a great quarter last month with revenue up 8% and earnings up as well as its full-year forecast.